Silicon Republic May 3, 2024
Laura Varley

Integration of Nvidia’s microservices and AWS will enable healthcare and life sciences companies to tackle complex challenges in drug discovery and digital health.

US chip giant Nvidia yesterday (2 May) announced the integration of its NIM cloud-native microservices with Amazon Web Services (AWS), in what is a significant development for the advancement of digital health and drug discovery.

VP of healthcare for the company Kimberly Powell made the announcement at the AWS Life Sciences Leader Symposium in Boston.

The collaboration represents a potentially transformative leap for the healthcare sector as it will give access to a vast collection of AI tools, including “foundation models for drug discovery, medical imaging and genomics, backed by enterprise-grade security and support”.

Professionals can...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Cloud, Pharma, Pharma / Biotech, Technology
HIMSSCast: Biden's executive order on AI is just the beginning
IHI report: The main use cases for genAI, their risks and ways to mitigate
How Businesses Can Navigate the AI Search Shake-Up
AI-powered WhatsApp messaging cleared for NHS pilot
Balancing excitement and caution with AI in healthcare

Share This Article